Associations of genetic variants of endothelin with cardiovascular complications in patients with renal failure

BMC Nephrol. 2017 Sep 7;18(1):291. doi: 10.1186/s12882-017-0707-2.

Abstract

Background: Cardiovascular (CV) complications are the main cause of death in end-stage renal disease (ESRD) patients. The high CV risks are attributable to the additive effects of multiple factors. Endothelin (EDN) is a potent vasoconstrictor and plays a role in regulating vascular homeostasis. However, whether variants of the EDN gene are associated with risks of CV events is not known. We conducted a study to investigate associations of variants of the EDN gene with CV events in ESRD patients.

Methods: A cohort of 190 ESRD patients was recruited, and 19 tagged single-nucleotide polymorphisms within the EDN gene family were selected for genotyping through a TaqMan assay. Data on clinical characteristics and hospitalizations for CV events were collected. Associations of genetic variants of the EDN gene with CV events were analyzed.

Results: In this cohort, 62% (n = 118) of patients were hospitalized for a CV event. The EDN1 rs4714384 (CC/TC vs. TT) polymorphism was associated with an increased risk of a CV event after multiple testing (p < 0.001). Further functional exploration showed that it was a quantitative trait locus which may significantly alter gene expression in the tibial artery.

Conclusions: EDN1 rs4714384 is very likely an important biomarker of CV events in ESRD patients.

Keywords: Cardiovascular; Endothelin; Renal failure.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Cardiovascular Diseases / complications
  • Cardiovascular Diseases / genetics*
  • Cohort Studies
  • Endothelin-1 / genetics*
  • Female
  • Genetic Association Studies
  • Genetic Variation / genetics*
  • Humans
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / genetics*
  • Male
  • Middle Aged

Substances

  • Endothelin-1